Gene Editing Delivery Summit 2023

Take advantage of the end-to-end content from discovery, optimization, evaluation, and scale-up topics covered in 2 hands-on workshops and 2 full days of data-driven case studies and discussion sessions from trailblazing drug developers such as Prime Medicine, Beam Therapeutics, Editas Medicine, and AstraZeneca to guide your in vivo gene editing delivery strategies for regulatory approval.